Format

Send to

Choose Destination
Adv Exp Med Biol. 2018;1050:1-12. doi: 10.1007/978-3-319-72799-8_1.

Economic Burden of Clostridium difficile Infection in European Countries.

Author information

1
Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. helenrei@hotmail.com.
2
Medicine Department, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain. helenrei@hotmail.com.
3
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. helenrei@hotmail.com.
4
Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. emilio.bouza@gmail.com.
5
Medicine Department, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain. emilio.bouza@gmail.com.
6
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. emilio.bouza@gmail.com.
7
CIBER de Enfermedades Respiratorias (CIBERES CB06/06/0058), Madrid, Spain. emilio.bouza@gmail.com.

Abstract

Clostridium difficile infection (CDI) remains a considerable challenge to health care systems worldwide. Although CDI represents a significant burden on healthcare systems in Europe, few studies have attempted to estimate the consumption of resources associated with CDI in Europe. The reported extra costs attributable to CDI vary widely according to the definitions, design, and methodologies used, making comparisons difficult to perform. In this chapter, the economic burden of healthcare facility-associated CDI in Europe will be assessed, as will other less explored areas such as the economic burden of recurrent CDI, community-acquired CDI, pediatric CDI, and CDI in outbreaks.

KEYWORDS:

C. difficile infection; Economic burden; Economic costs; Europe; Length of stay

PMID:
29383660
DOI:
10.1007/978-3-319-72799-8_1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center